EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Interplay of Type 1, Type 2, and Type 3 Lymphocytes and Cytokines in Atopic Dermatitis

Keiichi Yamanaka iD, Yui Kono, Shohei Iida, Takehisa Nakanishi, Mai Nishimura, Yoshiaki Matsushima iD, Makoto Kondo iD, Koji Habe, Yasutomo Imai

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24043310 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Keiichi Yamanaka und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Japan. Hauptthemen laut MEDLINE: Cytokines, Dermatitis, Atopic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Eli Lilly and Company, AbbVie GK, Sun Pharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD) is classified as a type 2 disease owing to the majority of type 2 lymphocytes that constitute the skin-infiltrating leukocytes. However, all of the type 1–3 lymphocytes intermingle in inflamed skin lesions. Here, using an AD mouse model where caspase-1 was specifically amplified under keratin-14 induction, we analyzed the sequential changes in type 1–3 inflammatory cytokines in lymphocytes purified from the cervical lymph nodes. Cells were cultured and stained for CD4, CD8, and γδTCR, followed by intracellular cytokines. Cytokine production in innate lymphocyte cells (ILCs) and the protein expression of type 2 cytokine IL-17E (IL-25) were investigated. We observed that, as inflammation progresses, the cytokine-producing T cells increased and abundant IL-13 but low levels of IL-4 are produced in CD4-positive T cells and ILCs. TNF-α and IFN-γ levels increased continuously. The total number of T cells and ILCs peaked at 4 months and decreased in the chronic phase. In addition, IL-25 may be simultaneously produced by IL-17F-producing cells. IL-25-producing cells increased in a time-dependent manner during the chronic phase and may work specifically for the prolongation of type 2 inflammation. Altogether, these findings suggest that inhibition of IL-25 may be a potential target in the treatment of inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytokinesDermatitis, AtopicAnimalsMiceCD4-Positive T-LymphocytesInterleukin-13Inflammation

Stichwörter der Autor:innen

atopic dermatitiscytokineinflammatory skin mouse modelinterleukin-17Einterleukin-25type 2 inflammation

Substanzen

CytokinesInterleukin-13

Autor:innen und Institutionen

  • Department of Dermatology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Japan.
  • Imai Adult and Pediatric Dermatology Clinic, 5-1-1 Ebie, Fukushima, Osaka 553-0001, Japan.

ORCID-Profile: Keiichi Yamanaka, Yoshiaki Matsushima, Makoto Kondo

Förderung

  • Eli Lilly and Company
  • AbbVie GK
  • Sun Pharma
  • Maruho Takagi Dermatology Foundation

Zitieren

APA

Yamanaka, K., Kono, Y., Iida, S., Nakanishi, T., Nishimura, M., Matsushima, Y., Kondo, M., Habe, K., & Imai, Y. (2023). The Interplay of Type 1, Type 2, and Type 3 Lymphocytes and Cytokines in Atopic Dermatitis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043310

Vancouver

Yamanaka K, Kono Y, Iida S, Nakanishi T, Nishimura M, Matsushima Y, et al. The Interplay of Type 1, Type 2, and Type 3 Lymphocytes and Cytokines in Atopic Dermatitis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24043310

BibTeX
@article{Yamanaka2023,
  author = {Yamanaka, Keiichi and Kono, Yui and Iida, Shohei and Nakanishi, Takehisa and Nishimura, Mai and Matsushima, Yoshiaki and Kondo, Makoto and Habe, Koji and Imai, Yasutomo},
  title = {The Interplay of Type 1, Type 2, and Type 3 Lymphocytes and Cytokines in Atopic Dermatitis},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24043310}
}
Kostenlos starten →